Rocket Doctor AI Inc. (CSE:AIDR)
Canada · Delayed Price · Currency is CAD | Market Cap | 57.27M +142.9% |
| Revenue (ttm) | 38.14K |
| Net Income | -2.01M |
| EPS | -0.17 |
| Shares Out | 95.45M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 205,945 |
| Average Volume | 179,425 |
| Open | 0.6000 |
| Previous Close | 0.6200 |
| Day's Range | 0.5900 - 0.6400 |
| 52-Week Range | 0.3300 - 0.9800 |
| Beta | -0.32 |
| RSI | 42.97 |
| Earnings Date | May 1, 2026 |
About Rocket Doctor AI
Rocket Doctor AI Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health. In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource. Rocket Doctor AI Inc. was formerly known as Treatment.com AI Inc. and ch... [Read more]
Financial Performance
Financial StatementsNews
Rocket Doctor Engages Danayi Capital for Digital Marketing Services
Vancouver, BC, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that it has engaged Danayi Capital Corp. (“Danayi”) to p...
ROCKET DOCTOR AI INC. ANNOUNCES CLOSING OF LISTED ISSUER FINANCING EXEMPTION (LIFE) PRIVATE PLACEMENT OF UNITS
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States
ROCKET DOCTOR AI INC. ANNOUNCES UPSIZE ON LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States Not for di...
Rocket Doctor Announces Granting of RSUs and Options
Vancouver, BC, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that the Company has granted an aggregate 75,000 stock o...
ROCKET DOCTOR AI INC. ANNOUNCES LISTED ISSUER FINANCING EXEMPTION (LIFE) NON-BROKERED PRIVATE PLACEMENT
Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States
Rocket Doctor AI Completes Acquisition of Alea Health to Expand Access to Therapist-Led Mental Health Care
Rocket Doctor AI has completed the acquisition of Alea Health, strengthening its AI-powered digital health platform and accelerating the delivery of physician-led care. The acquisition supports Rocket...
Rocket Doctor AI, Health Cities and CAN Health Network Partner to Advance AI-Powered Clinical Decision Support in Alberta
Vancouver, BC, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced a new partnership with the CAN Health Network to tes...
Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO
Vancouver, BC, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that Christopher Cherry shall assume the role of Interim...
Rocket Doctor Announces First in Canada Strategic Partnership with Toronto Metropolitan University to Support Clinical Education of Medical Learners on a Digital Health Platform
Vancouver, BC, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc.'s (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) wholly-owned digital health platform and marketplace Rocket Doctor...
Rocket Doctor AI Announces Strong Q3 Momentum Driven by U.S. Expansion, New Payer Contracts and Platform Growth
Continued organic quarter over quarter revenue growth despite expected summer seasonality Earnings per share for Q3, 2025: ($0.05) per share. Oversubscribed raise of C$4.23m contributing to significan...
Rocket Doctor Strengthens U.S. Leadership Team to Drive Growth and Expand Access to Care Coast to Coast
Vancouver, BC, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced its wholly-owned subsidiary Rocket Doctor Inc (“Rock...
Rocket Doctor AI Engages Fundamental Research Corp. for Analyst Coverage
Vancouver, BC, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) announces that we have engaged Fundamental Research Corp. (“FRC”), a...
ROCKET DOCTOR AI INC. ANNOUNCES ENGAGEMENT OF FN MEDIA GROUP
Vancouver, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Rocker Doctor AI Inc. (the “Company” or “Rocket Doctor AI”) (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) announces that it has engaged FN Medi...
NIH Awards US$2M Small Business Innovation grant to Transform How AI Collects Medical History
Bloomington, Minneapolis, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. (CSE: AIDR, OTC: AIRDF, Frankfurt: 939) (“Rocket Doctor AI”) today announced that its US-based subsidiary, Treatment.c...